The AI Drug Repurposing Market is expanding as pharmaceutical companies and research institutions increasingly use artificial intelligence to identify new therapeutic applications for existing drugs. AI-driven analysis of clinical, genomic, molecular, and biomedical data is helping accelerate drug discovery and improve the identification of potential treatment candidates. Growing investment in AI-enabled healthcare technologies, rising research costs, and the need to shorten drug development timelines are supporting market growth.
Advancements in machine learning, deep learning, and predictive analytics are creating new opportunities for identifying drug-disease relationships and optimizing therapeutic development. Increasing collaborations between pharmaceutical companies, biotechnology firms, technology providers, and academic institutions are further strengthening the market landscape. The market is expected to grow as AI-based approaches become increasingly integrated into pharmaceutical research and precision medicine.
FULL REPORT - https://dimensionmarketrese ...
